chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Sunday morning I woke up with a vibration sensation in my chest. The sensation lasted ten days followed by extreme chest pains that ended the ?vibration? sensation that had been non stop. Now I only have it randomly but the chest pains are random and sharp pains. I had talked to my doctor about it the following Tuesday feeling very convinced it?s from the vaccine. I have never in my life experienced anything like this. I?ve had anxiety for a better part of 16 years and this was completely different. I also do not believe it is my thyroid because I have had this condition for 10 years and have experienced this.  I was advised by my doctor to still get the second dose, but because of what happened previously I will not risk something going wrong with my heart. I will note during the duration of the ?vibration sensation? I had no pain until the very last day when the chest pains came on.
Received pneumoccoal injection 11/6/02. By 3pm that after noon had sever pain left arm (shoulder area). On Thursday, less pain. On Friday even less pain but by afternoon, rash or redness more like a redness or swelling. Swelling below were shot was given near elbow.
NO ADVERSE REACTION REPORTED.  GUARDIAN PROVIDED WRONG DOB ON VACCINE CONSENT FORM TO HAVE PATIENT BE 12 YEARS OLD THEREFORE AUTHORIZED FOR 12+ PFIZER COVID19 VACCINE.  VACCINATOR DID NOT HAVE INSURANCE INFORMATION AT THE TIME AND RAN AS "NEEDS FOLLOW-UP."  ACTUAL DOB WAS FOUND TO BE DIFFERENT WHEN TIME PERMITTED PHARMACY TO RESEARCH INSURANCE INFO.
Patient developed swelling and redness at the site of injection which continued progressing in size for 2 days. Area was 2 x 3 inches and erythematous. Slight warmth noted. No sign of secondary infection.
patient presented with an episode of anaphylaxis ten minutes after receiving the vaccine; This is a literature report.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The patient had no history of allergies.  The following information was reported: ANAPHYLACTIC REACTION (medically significant), outcome "unknown", described as "patient presented with an episode of anaphylaxis ten minutes after receiving the vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: There is a reasonable possibility that the event anaphylactic reaction was related to BNT162b2 based on known drug safety profile and close temporal relationship.,Linked Report(s) : US-PFIZER INC-202200014230 Same article/drug/event/ different patient;
A non-serious spontaneous report of half a dose of FLUMIST was received from a healthcare professional concerning a nine year-old. On an unspecified date the nurse forgot to pull the clip off the second half of the dose and the patient only received half a dose of FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
every few hours there would be a severe gripe midline just below waist, like 2 hands pushing insides together; enough to make me double over (and I tolerate pain quite well).  Followed by eventually an unusual kind of diarrhea/soft stool of unusual lumpy consistency . But flowing out but not real wet like diarrhea.  This event would happen about every 4 hours.  It lasted for 6 weeks then the gripe and soft stool quit.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient experienced apparent episode of syncope as he fell while standing up from chair and hit his head on the privacy screens surrounding the vaccination area. Patient did not appear to lose consciousness. Patient was very nervous prior to administration&experienced weakness that likely resulted in fall. Patient helped up my pharmacist, helped to chair to recover, and advised to reach out to PCP about potential head injury from fall. Encounter observed by pharmacist.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 19-AUG-2014 the patient was vaccinated with a expired dose of PNEUMOVAX 23 lot# J009827, expiration date 10-AUG-2014, intramuscular, Dose not reported. No known adverse effects. Additional information has been requested.
First Dose 02/05/21 at 12:30pm : Sore arm for 48hours, loss of appropriate taste on 02/06/21 from morning to evening. Second Dose 02/26/21 at 10:00am: Violent chills and joint/muscle aches, severe headache, diarrhea and fatigue beginning 02/26/21 at 11:30pm. Chills and body aches persist until 03/01/21 evening time. Fatigue, severe light-sensitive headache, and diarrhea still persist through today 03/05/2021.
Redness around the injection site about the size of a half dollar, warm to touch. Pain from the elbow to the neck on the right arm.
35 minutes Post injection patient reported that he could not breathe and went to a clinic.  Doctor examined him and saw no signs of anaphylactic reaction, however his thyroid was significantly swollen.
She also had pain in her arm; the second dose she states she also had fever; pain all over her body; This is a spontaneous report from a Pfizer sponsored program via a contactable consumer (patient). A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications of the patient were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization and experienced pain in arm. On an unspecified date after second dose of vaccination, patient experienced pain in her arm, also had fever and pain all over her body. Caller stated she knew this was normal. Outcome of the events were unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
14 hours after injection, experienced severe headache, bode aches, high fever, unable to eat, nausea, brain fog.  Could not move all of Friday, 4/22.  Saturday, 4/23, was just at about 50% of "normal".
Vaccinator stated that she missed patient being 17 at the time of the shot and that only Pfizer is currently indicated for 12 years and older.  She was counseled and understands verifying age and type of vaccine for appropriate recommended administration.  Spoke to patient, and she realized afterwards that she should have received Pfizer.  No adverse reactions noted aside from mild low-grade fever.
pt ate dinner that evening 6PM then parent noted both eyes swelling by bed time, one eye worse than the other but not sure which one;parent  had waited for MMW per MD request till pt had eaten egg in office;still edema in both eyes;
flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042BZ1A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (The patient's medical history was not provided.).    On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-101555 (E2B Linked Report). This case was linked to MOD-2021-101685 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101555:Crosslinked case
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Apr2022 at 11:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 51 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "Known allergies: Sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (19May2022) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.   Clinical course: Anti viral brand=PAXLOVID was given from 10May2022 to 14May2022, for treatment of COVID-19. Other medication in 2weeks was unknown.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
patient developed muscle and joint stiffness 5 days after vaccine administration that persisted, she was diagnosed with PMR  on 3/24/21 when her symptoms were not resolving
I lost my memory on Friday, March 26, at 10 pm. I do not remember what I did Wednesday-Friday, and the information I am providing is what my family and boyfriend have informed me about. I received my second Pfizer dose on Wednesday, March 24, at 11 am on my right arm. At 8 pm, I had a horrible migraine, body ache, and 101 fever. On Thursday, the fever was gone, and I just had a body ache and severe headache. On Friday, the body ache was gone, but the migraine was still present. I drove to my boyfriend's house at 8 pm. At 10 pm I informed my boyfriend that for 5 minutes I forgot where I was and that I forgot his room. He told me that I complained of a pounding headache that felt like it took over my whole head.  My boyfriend said to me that I had body chills and that my head was warm, but my hands were freezing. The last thing I said to him before I lost my memory was that the headache was getting worse.   A minute later, I started panicking because I forgot my birthday and my name. He said that I had brain fog and that I lost my memory. I was in a dream-like state and looked confused. I thought I was ten years old and could not remember certain family members or who I was. I was informed I lost my memory for 12 hours. On Saturday, I woke up and did not recall what happened the previous night. It felt like I woke up from a long sleep. My headache was still present, and my head felt foggy. I have tried to remember those three days, and when I try, the headaches become severe.  I reported this to my doctor, and she informed me that I need to report this since the same thing happened to my mother. She received the first Pfizer vaccine on March 3, at 11 am, and on March 7, she lost her memory. The only difference between my mother and I is that she lost her memory after the first vaccine, and  I lost my memory after the second vaccine.  I lost my memory for 12 hours, and for her, it was 24 hours. We both lost three days, and when we try to remember, we get headaches.
no adverse reactions or side effects experienced; pt received hepatitis B vaccine on 05-MAR-2010, 09-APR-2010 and on 27-OCT-2010; This spontaneous report as received from a lawyer refers to a 56-year-old female patient. The patient's concurrent conditions, medical history and concomitant therapy were captured in case MARRS # 2008USA003864.  The patient was vaccinated with hepatitis b vaccine (recombinant)(manufacturer unknown) (lot#, expiration date, dose, route of administration and anatomical location were not reported) on 05-MAR-2010, on 09-APR-2010 and on 27-OCT-2010. She experienced no adverse reactions or side effects.  This is one of 2 reports concerning the same patient.; Sender's Comments:  US-009507513-2008USA003864:
Doses were administered after the 30 day BUD; NO ADVERSE EVENT; Doses were administered after the 30 day BUD between 8-15JUN2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD between 8-15JUN2023.), PRODUCT STORAGE ERROR (Doses were administered after the 30 day BUD) and NO ADVERSE EVENT (NO ADVERSE EVENT) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.    In June 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In June 2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD between 8-15JUN2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Doses were administered after the 30 day BUD) and NO ADVERSE EVENT (NO ADVERSE EVENT). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD between 8-15JUN2023.), PRODUCT STORAGE ERROR (Doses were administered after the 30 day BUD) and NO ADVERSE EVENT (NO ADVERSE EVENT) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (NO ADVERSE EVENT) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD between 8-15JUN2023.) and PRODUCT STORAGE ERROR (Doses were administered after the 30 day BUD).    Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter. This case contains information about patient 3rd out of 7   This case was linked to US-MODERNATX, INC.-MOD-2023-729901 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-729901:(case Patient no-1)
The vaccine that was administered to the patient had passed its beyond use date/time.  The vial used had been removed from the refrigerator and punctured at 3:42pm the previous day.  The vaccine was administered within 24 hours of the vial being punctured/removed from the refrigerator.
Pt. felt severe sweating, cold skin clammy hand. Fever > 101. 2 days after (100). Blurred vision and darker spots. 10/9/11 muscle aches felt extreme pressure in head.
Nausea, restlessness, headache, dizziness. I continue to experience tingling on left extremities, i.e. side of face, arm, hand, leg, and foot; nausea and headache when tingling intensifies; tingling increases during evening hours to point of soreness in leg by time I go to bed; subsides during the night; begins again as I start moving around in the morning and when sitting position. During the day the tingling sensation goes across my chin at various parts of the day.
I woke up the morning after receiving the vaccine very dizzy. The vertigo persisted for 2 days so far. At one point, the vertigo caused me to throw up.
Client told me that he had already received dose 1 of a COVID vaccine, but could not remember which one. While I was answering questions for another client, another nurse assisting with immunizations came up to client to give him his J&J immunization and she asked client several times if he had received any previous COVID vaccines and he told her 'no,' so she administered the vaccine. Client was watched for 15 minutes and experienced no adverse effects from the immunization. Client is currently incarcerated at the county jail and is under 24/7 surveillance so he will be closely monitored for any adverse events in the coming days.
Missed period. Over by more than a month. Thrown off cycle. Doctor has to prescribe drugs to bring my period back.
rapid heart beat; elevated blood pressure; heart palpitations; anxiety; body aches; joint aches; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart beat), BLOOD PRESSURE INCREASED (elevated blood pressure), PALPITATIONS (heart palpitations), ANXIETY (anxiety) and PAIN (body aches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event .     On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced HEART RATE INCREASED (rapid heart beat), BLOOD PRESSURE INCREASED (elevated blood pressure), PALPITATIONS (heart palpitations), ANXIETY (anxiety), PAIN (body aches) and ARTHRALGIA (joint aches). On 30-Jan-2021, HEART RATE INCREASED (rapid heart beat), BLOOD PRESSURE INCREASED (elevated blood pressure), PALPITATIONS (heart palpitations), ANXIETY (anxiety), PAIN (body aches) and ARTHRALGIA (joint aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
She has redness, tenderness and local temperature elevation at the site of injection. - notice today.  Treatment - Ice, Bendryl, Ibuprofen and monitor.  Will be monitored closely to see if that speads.
After initial common side effects (headache, chills, lethargy) lasting no more than 18 hours after injection, I felt great until day 9 post vaccination.  Injection site became very inflamed, red, itching, painful. It spread the length of upper arm and around inside of arm.  General all over body itching began about 12 hours after initial redness near injection site.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (lot of pain all over her body), PYREXIA (Fever / thinks that the pain was caused by the fever) and HEADACHE (Headache) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. No Medical History information was reported. On 11-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, the patient experienced PAIN (lot of pain all over her body), PYREXIA (Fever / thinks that the pain was caused by the fever) and HEADACHE (Headache). At the time of the report, PAIN (lot of pain all over her body), PYREXIA (Fever / thinks that the pain was caused by the fever) and HEADACHE (Headache) outcome was unknown. No treatment medication was reported. No concomitant medication was reported. This case was linked to MOD-2022-454729 (Patient Link).
Patient reported diarrhea, headache, fever, chills, muscle pain throughout body, nausea, tightening of throat, and angioedema of bottom lip.
This was my 3rd Covid shot.  About 20 minutes after leaving the pharmacy my face felt numb on one side as did my arm and hand.  I didn't get much sleep the night before so I went home and slept for several hours.  It had lessened but was still felt.  The next day it was okay.
Very mild but noticeable numbness in tongue towards back of tongue (not front) on either side.  Seemed to dissipate after six hours.  Was not immediately noticeable and seemed to be more pronounced about 1/2 hour after injection.  I had the other expected soreness at injection site and general malaise approximately 24 hours after  - 96 hours after vaccine and I am only reporting this as I was not expecting the numbness in the tongue and was not sure if it was an adverse effect or just stress related.
At 10:45 am on 02/11/2021 begin to have difficulty speaking. Reports the symptom as "losing his voice". He states that the symptom continued to get worse and at 11:15 am he could not speak and was experiencing shortness of breath and throat tightness. He was taken to the local emergency room by another staff member. Does report he has had a history of having a anaphylatic response but not to a vaccine. He does not have a epinephrine pen prescribed to him.
Patient has vomiting  and light headache. Gave Gatorade and use ice pack on head.
Information has been received from a registered nurse (R.N) concerning a 69 year old male patient who in approximately February 2010, was vaccinated with a second dose of PNEUMOVAX 23 (dose and route not reported, lot number 664653/1337Y). Concomitant medications not reported. Nurse reported the patient complained about severe arm pain. Patient could not  move his arm. The patient recovered from the events. The nurse was concerned about the lot number and thought they may have received a "bad lot". She indicated that the office gives a lot of this vaccines and found it odd there were 3 patients who had similar experience in a short amount of time. The reporter did not specify if the patient sought medical attention. This is one of 3 reports from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information is not expected.
I'm a ID physician who self prescribed Vivotif. With first capsule on 2/4/15 I had some abdominal pain. Lasted one day. Then with 4th pill again symptoms recurred. Went to ER. The WBC count was 14k and CT scan showed enteritis.
Pt vaccinated w/ Rubella Approx 1 wk later developed a fever, rash described as pink patches w/macules on upper chest & neck, & headaches behind eyes with problems focusing her vision. Rash spreaded to face, back & developed swollen glands.
Injection site soreness; Injection site redness; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number 4H9G2, expiry date 25th September 2021) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 1st May 2019, refer linked case US2019AMR132554).   On 19th July 2019, the patient received the 2nd dose of Shingrix. On 19th July 2019, immediately after receiving Shingrix, the patient experienced injection site pain and injection site erythema. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain and injection site erythema were unknown.   It was unknown if the reporter considered the injection site pain and injection site erythema to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on right arm. Soon after, the patient experienced the same symptoms as soreness and redness at the injection site. The healthcare professional would like recommendations he could share with the patient. The reporter consented to follow up.